SDC1 and Miyoshi myopathy: Based on this, two scRNA-seq datasets, each profiling CD138+ PCs, a key marker of MM progression, were integrated to increase statistical power and sample diversity, enabling a more comprehensive characterisation of transcriptional changes across MM stages (Figure 4).